UUID:5855CEFD-CC67 4451 -A774-2SF8146067C7
m ll " TCGA-BH-A42V-91A-PR

IIHIIIII!IIIIIIIIIIIIIIIIIHIIIIII IIIIIIIIIﬁIIIIIed
WWW mun

III II” I II II IIIIIHIIHIH IIIIIIIIIII IIIIIIIIII I III
FINAL DIAGNOSIS: I” III” IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII IIIIIHIIIIIIIIIII
PART 1: SENTINEL LYMPH NODE #1. BIOPSY -

A. ONE LYMPI‘I NODE WITH MICROMETASTATIC CARCINOMA (1(1).
3. MICRO METASTA'HC TUMOR MEASURES 1 MM IN GREATEST DIMENSION.
O. NO EXT RACAPSULAR EXTENSION IS IDENTIFIED.

PART 2: SENTINEL LYMPH MODE #2, BIOPSY -
ONE LYMPH NODE. NEGATIVE FOR TUMOR (0“).

PART 3: SENTINEL LYMPH NODE #3, BIOPSY -
ONE LYMPH NODE, NEGATIVE FOR TUMOR (011).

PART 4: LEFT BREAST, SEGMENTAL MASTECTOMY AT 4 O'CLOCK -
A. INFILTRATINO DUCTAL CARCINOMA, 1.5 CM INGREATEST DIMENSION ASSOCIATED WITH

MICROCALCIFICATIONS. ‘
NornNGIIAM SCORE SIS (TUBULES 2. NUCLEAR GRADE 2, MITOTIC ACTIVITY 2), NOTTINGHAM GRADE 2).
NO LYMPHOVASCULAR INVASION Is IDENTIFIED. ‘
DUCTAL CARCINOMA IN SITu, CRIBRIFORM TYPE. NUCLEAR GRADE 2 WITH COMEDO-TYPE NECROSIS
AND ASSOCIATED MICROCALCIFICATIONS COMPRISING 3% OF INVASIVE TUMOR AND ALSO PRESENT IN
THE SURROUNDING BREAST TISSUE ‘
SURGICAL MARGINS ARE NEGATIVE FOR INFILTRATING DUCTAL CARCINOMA AND DUCTAL CARCINOMA
IN SITU.
INFILTRATING DUCTAL CARCINOMA Is FOCALLY PRESENT 3 MM AWAY FROM POSTERIOR MARGIN.
DUCTAL CARCINOMA IN SITU FOCALLY VERY CLOSELY APPTOACHES SUPERIOR MARGIN 0.2 MM).
ATYPICAL DUCTAL HYPERPLASIA.
PERIPHERAL PAPILLOMAS.
. DUCTAI. EPITHELIAL HYPERPLASIA AND COLUMNAR CELL CHANGE.
CASE SY OPSIS:

SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST

PP!”

”F?” m

L

LATERALITY: Left
PROCEDURE: Segmental
LOCATION: Clock positionz4200
SIZE OF TUMOR: , Maximum dimension invasive component: 15 mm
MULTICENTRICITYIMULTIFOCALI'IY OF INVASIVE FOCI:
NO ~ - , .
TUMOR TYPE (invasive component): I C D 0 3 ,
Ductal adenocarcinoma, Nos Coch In omq I (IF: I huh
NOTTINGHAM SCORE: Nuclear grade: 2 ' ’ ~
Tubula formation: 2 ' CI lkCIra, I , N 03
Mitotic activity score: 2 g 5‘00} 3

Total Nottingham score: 6 .
ﬂoﬂingham grade (1, 2. 3): 2 SI Io : brms—I I ND 5
0

ANGIOLYMPHATIC INVASION:

DERMAL LYMPHATIC INVASION: Not appIIoabIe C '50 .6?
CALCIFICATION: Yes, malignant zonoo CI 4 '4 2

TUMOR TYPE, IN SITU: Cribriform

Percent of tumor occupied by In situ component: 3 %
SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:

NO

Distance of invasive tumor to closest margin: 3 mm
SURG MARGINS INVOLVED BY IN SITU COMPONENT:

No

Distance of in situ disease to Closest margin: 0.2 mm

LYMPI-I MODES POSITIVE: 1

LYMPH NOI'JES EXAMINED: 3

METHOD(S) OF LYMPH NODE EXAMINATION:
HIE stain

SENTINEL NODE METASTASIS: Yes

SIZE OF NODAL METASTASES: Diameter of largest lymph node metastasis: 1 mm

LYMPH NOOE METASTASISI-ES) WITH EXTRACAPSULAB EXTENSION:
No

NON-NEOPLASTIC BREAST TISSUE: ADH. Papilloma, FCD

T STAGE, PATHOLOGIC: pT1C

N STAGE. PATHOLOGIC: pN‘lmi

M STAGE: ' Not appllcable

ESTROGEN RECEPTORS: positive

PROGESTERONE RECEPTORS: positive
HERZINEU: 1 +

 

